Educational Objectives

 Identify the complexities of cardiometabolic risk-management in
 patients with the metabolic syndrome.
 Evaluate the use of biomarkers in the prevention and treatment
 of atherosclerosis.

 Discuss epidemiologic and statistical evidence related to
 cardiovascular disease risk.
 Discuss clinical trials and their role in lipid and lipoprotein
 treatment in cardiovascular prevention.

Back to Lipidology Introduction